Windtree Therapeutics, Inc. WINT
0.00
0.00
NaN
as of 25 Sep
- Market cap
- $2.4M
- P/E
- 0.0×
Follow WINT
| Older periods | Dec '24 | Mar '25 | Jun '25 | Sep '25 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
0.31 | 0.18 | 0.02 | 0.01 | |
Current Ratio |
0.45 | 0.25 | 0.43 | 0.33 | |
Net Debt/EBITDA |
0.15 | 0.16 | (1.89) | (0.88) | |
Debt/Assets |
3.44% | 2.02% | 24.45% | 107.82% | |
Debt/Equity |
0.10 | 0.05 | 2.16 | (1.48) | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(54.19) | 0.48 | 0.18 | 0.22 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.87 | 0.90 | 0.76 | 0.50 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(70.06) | (2.21) | (0.54) | (0.24) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(70.06) | (2.21) | (0.54) | (0.24) | |
Cash per Share |
33.82 | 1.08 | 0.06 | 0.01 | |
Shareholders Equity per Share |
190.04 | 9.45 | 0.74 | (0.44) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
190.04 | 9.45 | 0.74 | (0.44) | |
Free Cash Flow |
(3.68) | (2.41) | (2.66) | (6.37) | |
Working Capital |
(3.14) | (4.88) | (8.94) | (14.70) | |
Capital Expenditures |
0.00 | — | — | — | |
Net Current Asset Value |
(15.30) | (14.88) | (21.43) | (20.39) | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | — | — | — | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
1.34 | 2.40 | 3.55 | 1.85 | |
Average Assets |
30.14 | 28.43 | 30.27 | 23.22 | |
Average Common Equity |
6.69 | 12.86 | 3.55 | (3.60) |
Columns are period end dates